PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
88.67%
Revenue growth above 1.5x AR's 29.42%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
189.76%
Gross profit growth above 1.5x AR's 50.34%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
1037.82%
Positive EBIT growth while AR is negative. John Neff might see a substantial edge in operational management.
1037.82%
Positive operating income growth while AR is negative. John Neff might view this as a competitive edge in operations.
2541.03%
Net income growth above 1.5x AR's 21.29%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
2595.00%
EPS growth above 1.5x AR's 20.41%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
2595.00%
Diluted EPS growth above 1.5x AR's 20.41%. David Dodd would see if there's a robust moat protecting these shareholder gains.
-0.18%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
No Data
No Data available this quarter, please select a different quarter.
-6.98%
Dividend reduction while AR stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
-36.84%
Negative OCF growth while AR is at 94.94%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-41.99%
Negative FCF growth while AR is at 186.27%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
-71.76%
Negative 10Y revenue/share CAGR while AR stands at 829.09%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
29.57%
5Y revenue/share CAGR under 50% of AR's 268.34%. Michael Burry would suspect a significant competitive gap or product weakness.
104.22%
3Y revenue/share CAGR under 50% of AR's 226.08%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
-78.47%
Negative 10Y OCF/share CAGR while AR stands at 542.92%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-6.30%
Negative 5Y OCF/share CAGR while AR is at 241.34%. Joel Greenblatt would question the firm’s operational model or cost structure.
10.34%
3Y OCF/share CAGR under 50% of AR's 331.00%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
-24.74%
Both face negative decade-long net income/share CAGR. Martin Whitman would suspect a shrinking or highly disrupted sector.
417.78%
5Y net income/share CAGR above 1.5x AR's 54.09%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
248.83%
Positive short-term CAGR while AR is negative. John Neff would see a clear advantage in near-term profit trajectory.
-74.49%
Negative equity/share CAGR over 10 years while AR stands at 282.97%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
12.04%
Below 50% of AR's 79.46%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
6.79%
Below 50% of AR's 15.05%. Michael Burry suspects a serious short-term disadvantage in building book value.
-96.59%
Cut dividends over 10 years while AR stands at 0.00%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
-74.19%
Negative 5Y dividend/share CAGR while AR stands at 0.00%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
-70.52%
Negative near-term dividend growth while AR invests at 0.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
-35.11%
Firm’s AR is declining while AR shows 31.27%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
No Data
No Data available this quarter, please select a different quarter.
0.17%
Positive asset growth while AR is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
14.88%
Positive BV/share change while AR is negative. John Neff sees a clear edge over a competitor losing equity.
-0.12%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
-24.18%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.